- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 21.95M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 21.94M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 19.33M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $1.37M |
| Capex | Q1 2025 · Mar 31, 2024 | $5.43M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$19.16M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$28.32M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.42M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.65M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $26.24M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $26.47M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $65.39M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $87.84M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $283.29M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $298.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $311.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $332.33M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $38.43M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $46.11M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $43.7M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $51.64M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $82.48M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $102.64M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $326.99M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $349.89M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.71 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.22 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.71 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.22 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $6.77M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $8.09M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$15.63M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$23.61M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$11.86M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$14.68M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $134K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $691K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $19.86M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $12.71M |
| Revenue | Q1 2025 · Mar 31, 2025 | $20M |
| Revenue | Q1 2025 · Mar 31, 2024 | $13.4M |